Mounjaro®
Starting from £179.99/mo
Start journey Learn moreBurping is one of the more reliably reported side effects of semaglutide — trial data place it among the most common gastrointestinal complaints, particularly in the first weeks of treatment. It tends to arrive alongside nausea and a slowed sense of fullness, and for some people it has a distinctly unpleasant sulphurous quality. The good news is that it usually settles as your body adjusts, and there are practical things that genuinely help. Like all effects of this kind, it is worth discussing with your prescriber, since semaglutide is a prescription-only medicine that requires clinical assessment and ongoing review before and during treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The STEP 1 trial (the foundational phase 3 study of semaglutide 2.4mg for weight management, published in the New England Journal of Medicine) found that gastrointestinal events were the most frequently reported side effects, affecting the majority of participants in the active treatment arm. Belching was captured within that cluster. The NHS semaglutide medicines page lists burping and indigestion among the common side effects, consistent with what was observed across the STEP programme. These effects were generally described as mild to moderate and, critically, were most concentrated around dose increases rather than persisting at a constant level throughout treatment.
The mechanism matters here. Semaglutide slows gastric emptying, the rate at which your stomach passes its contents into the small intestine. That is part of how it reduces appetite, but it also means food and gas sit in the upper gut longer. Swallowed air, which everyone takes in during eating and drinking, has more time to accumulate before the stomach empties, and the path of least resistance is back the way it came. That is the burp. If the burp carries a sulphurous smell, the cause is bacterial fermentation of food that has lingered too long in the stomach, a phenomenon explored further on our page about eggy burps on semaglutide.
Timing is relevant. Burping is not a fixed feature of life on semaglutide. Most people find it peaks in the first week or two after starting or after stepping up to a new dose, then recedes as the gut adapts. A prescriber can help you weigh whether symptoms are proportionate to the dose you are on, or whether a slower titration might suit you better.
Eating quickly is probably the single biggest amplifier. Fast eating means swallowing significantly more air with each mouthful, and on semaglutide that air has nowhere to go quickly. Slowing down (putting the fork down between bites, chewing thoroughly, taking five or ten minutes longer over a meal than you normally would) reduces the volume of air going in at the source.
Carbonated drinks are the other obvious culprit. Fizzy water, sparkling soft drinks, beer: all of them introduce gas directly into a stomach that is already moving slowly. Switching to still water during the period when burping is worst is a simple change that a lot of people on semaglutide find genuinely effective. Straws are worth avoiding for the same reason, they pull extra air in with each sip.
Meal size matters too. Because the stomach empties slowly, a large meal creates a larger gas reservoir and leaves you uncomfortable for longer. Smaller, more frequent meals reduce that load. High-fat foods are also worth moderating, fat delays gastric emptying further, compounding the effect semaglutide already has. Lying down shortly after eating gives gas less gravitational help to move downward and more reason to head upward instead.
For a fuller picture of how burping sits within semaglutide's broader gastrointestinal profile, the Wegovy side effects page covers nausea, diarrhoea, constipation and the rest of the cluster together. And if the quality of your burps is the main concern, our separate page specifically on whether semaglutide causes sulphur burps goes into the bacterial fermentation angle in more detail.
For most people, burping on semaglutide is an annoyance rather than a warning. There are exceptions. Severe, persistent abdominal pain (especially pain that radiates toward the back and does not ease) requires urgent medical attention because it can be a sign of acute pancreatitis, a rare but serious condition associated with GLP-1 medicines. The MHRA highlighted this in its January 2026 Drug Safety Update for GLP-1 medicines; that guidance is available through the MHRA Yellow Card scheme, where patients can also report any suspected side effects directly.
Gallbladder symptoms (pain in the upper right abdomen, particularly after eating, sometimes with nausea) are also worth reporting promptly. Dehydration from severe vomiting or diarrhoea is another reason to seek advice sooner rather than later. If burping is accompanied by any of these, speak to a clinician or call 111 rather than waiting for your next scheduled review.
Persistent burping that does not improve after a few weeks at a stable dose, or that is significantly affecting your quality of life, is worth raising with your prescriber before your next routine check-in. There is no obligation to tolerate it in silence. The burping on semaglutide page looks at this from a slightly different angle if you want more detail on the duration question. You can also read about related gut symptoms, including changes in stool colour on Wegovy, which occasionally accompany the broader GI adjustment period.
For context on what Wegovy treatment involves more broadly, including how the dose schedule works and what to expect across the titration period, the Wegovy overview is a reasonable starting point. If you are thinking about whether a clinical assessment makes sense for you, our treatment consultation page explains how the process works at nume. Consultations are free, and reviewed the same day by a GPhC-registered prescriber, a real clinician reads your answers, not software. You can also review our approach to clinical oversight on the clinical team page.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.